Frankfurt - Delayed Quote EUR
BioNTech SE (22UA.F)
83.75
+0.80
+(0.96%)
As of 7:20:38 PM GMT+2. Market Open.
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in EUR | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 11 | 11 | 20 | 19 |
Avg. Estimate | 136.87M | 763.27M | 2.07B | 2.2B |
Low Estimate | 82.26M | 486M | 1.7B | 1.42B |
High Estimate | 406.4M | 1.23B | 2.73B | 3.54B |
Year Ago Sales | 128.7M | 1.24B | 2.75B | 2.07B |
Sales Growth (year/est) | 6.35% | -38.68% | -24.72% | 5.99% |
EPS Trend
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
22UA.F | -- | -- | -- | -- |
S&P 500 | 12.66% | 3.22% | 7.99% | 13.82% |
Upgrades & Downgrades
Maintains | Citigroup: Buy to Buy | 5/6/2025 |
Maintains | Morgan Stanley: Overweight to Overweight | 5/6/2025 |
Maintains | HC Wainwright & Co.: Buy to Buy | 4/1/2025 |
Initiated | Citigroup: Buy | 3/13/2025 |
Maintains | Morgan Stanley: Overweight to Overweight | 3/11/2025 |
Maintains | Canaccord Genuity: Buy to Buy | 3/11/2025 |
Related Tickers
0QF.F Moderna, Inc.
21.69
+1.45%
BV3.DU Bavarian Nordic A/S
20.75
+0.78%
3G0.F Altimmune, Inc.
4.6880
+5.49%
5CV.F CureVac N.V.
3.1060
+1.37%
NVV1.F Novavax, Inc.
6.19
+13.71%
0QF.DE Moderna, Inc.
21.52
+2.26%
HOPHF Hemogenyx Pharmaceuticals Plc
1.2400
0.00%
GLPG.AS Galapagos NV
22.56
-2.08%
ONT.L Oxford Nanopore Technologies plc
130.90
+9.63%
KYTX Kyverna Therapeutics, Inc.
2.1100
+4.46%